INTERCEPT is not approved for sale in the US and certain other countries.
SIGN UP FOR OUR
E-NEWSLETTER
INTERCEPT eNews delivers product news & information updates.
- Product Overview
- Resource Center
- INTERCEPT In Use
- News & Events
- Recent News and Events
- ISBT 2013 Amsterdam
- Cerus Announces FDA Agreement on Modular Premarket Approval (PMA) Application Submission Process for INTERCEPT Platelets
- Swissmedic and Swiss Red Cross Present National Haemovigilance Data Showing Favourable Safety Profile for INTERCEPT-Treated Platelet Components
- Cerus Signs INTERCEPT Platelet Agreements With Two Key Blood Component Suppliers in Germany and Austria
- Cerus to proceed with submission for U.S. approval of INTERCEPT Platelets
- Cerus Announces FDA Agreement on Modular Premarket Approval Application (PMA) Submission Process for INTERCEPT Plasma
- Cerus Signs Agreement With Swiss Red Cross for Initial Deployment of the INTERCEPT Blood System for Plasma
- Cerus to Seek INTERCEPT Plasma Approval in the U.S.
- AABB 2012 Boston
- Webinar Series
- Symposium Webcasts
- eNews Archive
- Recent News and Events
